For example, systemic delivery of a gene-replacement therapy with AAV-PHP.B (the parental serotype of AAV-PHP.eB) provided significant benefit in an Ndufs4 knockout mouse model of Leigh syndrome,59 where previous attempts using AAV163 and AAV2/964 serotypes resulted in less improvement. Here, NDUFS4 is linked to Leigh syndrome.